PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 31203411-9 2019 However, cell pretreatment with 8-methoxypsoralen (0.1-1 microM), a potent inhibitor of CYP2A, resulted in a 90% decrease of 4-ABP DNA adducts levels. Methoxsalen 32-49 cytochrome P450 family 2 subfamily A member 13 Homo sapiens 88-93 17671098-8 2007 Furthermore, the addition of 8-methoxypsoralen, a CYP2A inhibitor, led to greater inhibition of NNK metabolic activation in microsomes containing relatively high levels of CYP2A13 than in samples containing no detectable CYP2A13. Methoxsalen 29-46 cytochrome P450 family 2 subfamily A member 13 Homo sapiens 50-55 22743290-9 2012 Finally, treatment with nicotine, a competitor of AFB(1), and 8-methoxypsoralen (8-MOP), an inhibitor of CYP enzyme, further confirm the critical role of CYP2A13 in AFB(1)-induced cytotoxicity and apoptosis. Methoxsalen 62-79 cytochrome P450 family 2 subfamily A member 13 Homo sapiens 154-161 22743290-9 2012 Finally, treatment with nicotine, a competitor of AFB(1), and 8-methoxypsoralen (8-MOP), an inhibitor of CYP enzyme, further confirm the critical role of CYP2A13 in AFB(1)-induced cytotoxicity and apoptosis. Methoxsalen 81-86 cytochrome P450 family 2 subfamily A member 13 Homo sapiens 154-161 18215451-3 2008 8-Methoxypsoralen (8-MOP) is a mechanism-based inhibitor of human CYP2A6 and CYP2A13. Methoxsalen 0-17 cytochrome P450 family 2 subfamily A member 13 Homo sapiens 77-84 18215451-3 2008 8-Methoxypsoralen (8-MOP) is a mechanism-based inhibitor of human CYP2A6 and CYP2A13. Methoxsalen 19-24 cytochrome P450 family 2 subfamily A member 13 Homo sapiens 77-84 23907605-7 2013 All the above effects were inhibited by nicotine (a substrate of CYP2A13) or 8-MOP (an inhibitor of CYP enzymes), confirming that CYP2A13 mediated the AFG1-induced cytotoxicity and DNA damages. Methoxsalen 77-82 cytochrome P450 family 2 subfamily A member 13 Homo sapiens 130-137 22696418-8 2012 However, 8-methoxypsoralen has a 6-fold lower K(i) for CYP2A13 than for CYP2A6. Methoxsalen 9-26 cytochrome P450 family 2 subfamily A member 13 Homo sapiens 55-62 17671098-8 2007 Furthermore, the addition of 8-methoxypsoralen, a CYP2A inhibitor, led to greater inhibition of NNK metabolic activation in microsomes containing relatively high levels of CYP2A13 than in samples containing no detectable CYP2A13. Methoxsalen 29-46 cytochrome P450 family 2 subfamily A member 13 Homo sapiens 172-179 17671098-8 2007 Furthermore, the addition of 8-methoxypsoralen, a CYP2A inhibitor, led to greater inhibition of NNK metabolic activation in microsomes containing relatively high levels of CYP2A13 than in samples containing no detectable CYP2A13. Methoxsalen 29-46 cytochrome P450 family 2 subfamily A member 13 Homo sapiens 221-228